Compositions and methods for imaging cancer
US10150804B2 · kind B2 · utility
4Cited by
5References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 2, 2015 |
| Grant date | Dec 11, 2018 |
| Priority date | — |
| Expiry date | Mar 29, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/083
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Somatostatin derivative compounds of general formula (I) that may be readily labelled with the isotope fluorine-18 and that have affinity and selectivity for cellular somatostatin receptors are provided. The labelled compounds are useful clinically as radioactive tracers in various in vivo imaging applications (for example, using positron emission tomography (PET) and related techniques) to detect somatostatin-expressing cells and tissues, including tumors, or as therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.